Appointment to Executive Committee

21 August 2017

Reading, United Kingdom (21 August 2017) – Convatec Group Plc (“Convatec” or “the Company”) announces the appointment of Donal Balfe as Executive Vice President Global Operations and member of the Executive Committee of the Company, with effect from 1 October 2017.

Since 2009, Donal has been Vice President of Operations for Medtronic PLC, where he was responsible for 13 manufacturing sites comprising the European and Asian manufacturing operations and the Renal Care Solutions business unit of Medtronic’s MITG group. In this role, Donal supervised continuous change actions to improve service and business performance, reduce costs, enhance quality and increase margins, within a regulated environment. He has also led programmes to consolidate manufacturing operations and implement Six Sigma and Lean manufacturing initiatives.

Prior to joining Medtronic, Donal was Vice President of Manufacturing at Covidien. He has 29 years of experience in Medical Device manufacturing, having started his career with Bayer Corporation.

Paul Moraviec, Chief Executive Officer of Convatec, said:

“I am delighted to announce Donal’s appointment to lead our manufacturing operations and the execution of our Margin Improvement Programme. He brings exceptional experience of the Medical Technology sector and operational management to our Company and I look forward to working with him to deliver on the targets that we have set ourselves.”

About Convatec

Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Convatec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com

Enquiries

Analysts and Investors

John Crosse, VP Investor Relations, Convatec +44 (0)7500 141 435

Kirsty Law, Director Investor Relations, Convatec +44 (0)7470 909 582

investorrelations@convatec.com

Media

Bobby Leach, VP Group Corporate Affairs, Convatec +44 (0)7770 842 226

Alastair Elwen, Finsbury +44 (0)207 251 3801

Press Release

See all

04-Dec-17

Corporate

Our People

Organisation Appointments

16-Oct-17

Corporate

Financial Performance

FY2017 guidance and third quarter update

19-Sep-17

Continence Care

Convatec Introduces GentleCath™ Glide and me+™ Continence Care Programme for Intermittent Catheter Users in Europe

11-Sep-17

Corporate

Financial Performance

Scrip Dividend

21-Aug-17

Corporate

Our People

Appointment to Executive Committee

14-Aug-17

Corporate

Our People

Convatec appoints two Non-Executive Directors

03-Aug-17

Ostomy Care

Convatec Launches Natura™ Convex Accordion Flange™, Designed to Make Ostomy Pouch Application Easier and More Comfortable

03-Aug-17

Corporate

Convatec Announces 2017 Interim results

03-Aug-17

Corporate

Our People

Board Changes

20-Jul-17

Corporate

Continence Care

Convatec Announces Acquisition of Woodbury Holdings

09-Jun-17

Corporate

Our People

Announcement on Board of Directors

04-May-17

Corporate

Financial Performance

Trading Update for the three months ended 31 March 2017

02-May-17

Ostomy Care

Convatec Announces U.S. FDA 510(k) Clearance and Launch of Flexi-Seal™ PROTECT Fecal Management System

07-Apr-17

Advanced Wound Care

Independent Study Finds Significant Decrease in Post-Operative Joint Infections with AQUACEL® Ag SURGICAL Cover Dressing

05-Apr-17

Advanced Wound Care

Convatec Announces U.S. Launch of Foam Lite™ ConvaTec Dressing, Providing Customers with Wider Choice for Variety of Wounds

03-Apr-17

Corporate

Our People

Boards 3 April 2017 - Executive Committee